Biomolecular Engineering
-
UCSC iGEM developing yeast-based type 2 diabetes medication for 2022 international competition
14 UCSC undergraduates are addressing access and cost of Type 2 diabetes medications by creating an alternative, yeast-based treatment that will be presented at the 2022 iGEM Jamboree in Paris.
-
ASPIRE program launches to aid conservation in a changing climate
A new program out of the UC Santa Cruz Genomics Institute involves students in an effort to measure changes in biodiversity and ultimately prevent them.
-
UCSC scholars join researchers statewide on a massive genomic study of California’s biodiversity
The California Conservation Genomics Project (CCGP) is a state-funded initiative with a single goal: to produce the most comprehensive, multispecies genomic dataset ever assembled to help manage regional biodiversity.
-
Prestigious $3.8M NIH grant awarded to biomolecular engineering professor to develop an RSV vaccine
Associate Professor of Biomolecular Engineering Rebecca DuBois will use the five-year grant to develop a vaccine for respiratory syncytial virus, a common and potentially dangerous virus.
-
Karen Miga named one of TIME’s 100 Most Influential People of 2022
Karen Miga, assistant professor of biomolecular engineering at UC Santa Cruz, was named one of the 100 most influential people of 2022 by TIME. The honor was announced on May 23.
-
Institute for the Biology of Stem Cells awarded $1M training grant for postdoctoral researchers
The directors of the Institute for the Biology of Stem Cells brought in a new $1M training grant for postdoctoral researchers, and have been awarded over $12M in grants in just two years.
-
First complete, gapless sequence of a human genome reveals hidden regions
Parts of the human genome now available to study for the first time are important for understanding genetic diseases, human diversity, and evolution.
-
New study confirms bioengineered RSV protein vaccine evokes protective immune response
Two UC Santa Cruz researchers just marked a major milestone in their effort to create an effective vaccine for respiratory syncytial virus (RSV), which can cause severe respiratory disease in children and the elderly.
-
New responsible data sharing technique will enable better understanding of disease-causing genetic variants
Scientists may better understand and test for the genetic variations that cause cancer and other heritable diseases through the application of a novel strategy for securely sharing and analyzing genomic data developed at the UC Santa Cruz Genomics Institute.
-
A new way to find genetic variations removes bias from human genotyping
Researchers at the UC Santa Cruz Genomics Institute have demonstrated an effective new tool for mapping genetic variants in sequencing data using ‘pangenomics’ instead of a single reference genome .
-
UCSC team scores gold for second straight year at iGEM synthetic biology competition
For the second year in a row, a team of UC Santa Cruz undergraduates won a gold medal at the International Genetically Engineered Machine (iGEM) Jamboree.